Estimating Childhood Stunting and Overweight Trends in the European Region from Sparse Longitudinal Data.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
06 07 2022
Historique:
received: 24 11 2021
revised: 01 03 2022
accepted: 16 03 2022
pubmed: 30 3 2022
medline: 9 7 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

Monitoring countries' progress toward the achievement of their nutrition targets is an important task, but data sparsity makes monitoring trends challenging. Childhood stunting and overweight data in the European region over the last 30 y have had low coverage and frequency, with most data only covering a portion of the complete age interval of 0-59 mo. We implemented a statistical method to extract useful information on child malnutrition trends from sparse longitudinal data for these indicators. Heteroscedastic penalized longitudinal mixed models were used to accommodate data sparsity and predict region-wide, country-level trends over time. We leveraged prevalence estimates stratified by sex and partial age intervals (i.e., intervals that do not cover the complete 0-59 mo), which expanded the available data (for stunting: from 84 sources and 428 prevalence estimates to 99 sources and 1786 estimates), improving the robustness of our analysis. Results indicated a generally decreasing trend in stunting and a stable, slightly diminishing rate for overweight, with large differences in trends between low- and middle-income countries compared with high-income countries. No differences were found between age groups and between sexes. Cross-validation results indicated that both stunting and overweight models were robust in estimating the indicators for our data (root mean squared error: 0.061 and 0.056; median absolute deviation: 0.045 and 0.042; for stunting and overweight, respectively). These statistical methods can provide useful and robust information on child malnutrition trends over time, even when data are sparse.

Sections du résumé

BACKGROUND
Monitoring countries' progress toward the achievement of their nutrition targets is an important task, but data sparsity makes monitoring trends challenging. Childhood stunting and overweight data in the European region over the last 30 y have had low coverage and frequency, with most data only covering a portion of the complete age interval of 0-59 mo.
OBJECTIVES
We implemented a statistical method to extract useful information on child malnutrition trends from sparse longitudinal data for these indicators.
METHODS
Heteroscedastic penalized longitudinal mixed models were used to accommodate data sparsity and predict region-wide, country-level trends over time. We leveraged prevalence estimates stratified by sex and partial age intervals (i.e., intervals that do not cover the complete 0-59 mo), which expanded the available data (for stunting: from 84 sources and 428 prevalence estimates to 99 sources and 1786 estimates), improving the robustness of our analysis.
RESULTS
Results indicated a generally decreasing trend in stunting and a stable, slightly diminishing rate for overweight, with large differences in trends between low- and middle-income countries compared with high-income countries. No differences were found between age groups and between sexes. Cross-validation results indicated that both stunting and overweight models were robust in estimating the indicators for our data (root mean squared error: 0.061 and 0.056; median absolute deviation: 0.045 and 0.042; for stunting and overweight, respectively).
CONCLUSIONS
These statistical methods can provide useful and robust information on child malnutrition trends over time, even when data are sparse.

Identifiants

pubmed: 35349691
pii: S0022-3166(22)00662-9
doi: 10.1093/jn/nxac072
pmc: PMC9258559
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1773-1782

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Références

Am J Hum Biol. 2012 Jan-Feb;24(1):5-13
pubmed: 22121058
Lancet. 2013 Aug 10;382(9891):525-34
pubmed: 23541370
BMC Pediatr. 2007 Apr 10;7:17
pubmed: 17425787
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Lancet. 2008 Jan 19;371(9608):243-60
pubmed: 18207566
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33328202
Adv Nutr. 2019 Mar 1;10(2):196-204
pubmed: 30801614
Am J Clin Nutr. 2010 Nov;92(5):1257-64
pubmed: 20861173
Lancet. 2010 May 15;375(9727):1737-48
pubmed: 20451244
Epidemiology. 2010 Jul;21 Suppl 4:S17-24
pubmed: 21422965
N Engl J Med. 2005 Apr 14;352(15):1514-6
pubmed: 15829531
Stat Med. 2019 Mar 15;38(6):1002-1012
pubmed: 30430613
Int J Epidemiol. 2003 Aug;32(4):518-26
pubmed: 12913022
Int J Pediatr Obes. 2006;1(1):11-25
pubmed: 17902211
Matern Child Nutr. 2016 May;12 Suppl 1:12-26
pubmed: 27187907
BMC Med Res Methodol. 2013 Jul 31;13:100
pubmed: 23902644

Auteurs

Chitra M Saraswati (CM)

Department of Nutrition and Food Safety, WHO, Geneva, Switzerland.

Elaine Borghi (E)

Department of Nutrition and Food Safety, WHO, Geneva, Switzerland.

João J R da Silva Breda (JJR)

Quality of Care Office, WHO Regional Office for Europe, Athens, Greece.

Monica C Flores-Urrutia (MC)

Department of Nutrition and Food Safety, WHO, Geneva, Switzerland.

Julianne Williams (J)

Regional Office for Europe, WHO, Geneva, Switzerland.

Chika Hayashi (C)

Division of Data, Analytics, Planning and Monitoring, UNICEF, New York, NY, USA.

Edward A Frongillo (EA)

Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Alexander C McLain (AC)

Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH